global expansion

Houston biotech company continues to expand in Brazil with new research partner

Cemvita has partnered with Brazilian sustainable research institution REMA. Photo courtesy of Cemvita

Houston biotech company Cemvita has announced a strategic collaboration with Brazilian sustainable research institution REMA.

The move aims to promote Cemvita’s platform for evaluating and testing carbon waste streams as feedstocks for producing sustainable oil, according to the company.

Cemvita utilizes synthetic biology to transform carbon emissions into valuable bio-based chemicals. REMA professors Marcio Schneider and Admir Giachini have previously worked with Cemvita’s CTO, Marcio Busi da Silva, for approximately 20 years.

“This long-standing partnership reflects not only our strong professional ties, but also our shared commitment to advancing science and technology for a more sustainable future," Busi da Silva said in a news release.

REMA’s center is based in Florianópolis and is affiliated with the Federal University of Santa Catarina, which develops cost-effective environmental and technological solutions in automation, chemical engineering, biotech, environmental engineering and agronomy.

“Partnering with REMA in Florianópolis represents a significant step forward in our mission to transform carbon waste into valuable resources,” Tara Karimi, chief science and sustainability officer of Cemvita, said in a news release. “Together, we will enhance our platform’s capabilities, leveraging REMA’s expertise to evaluate and utilize diverse waste streams for sustainable oil production, further advancing the circular bioeconomy in Brazil and beyond.”

Cemvita recently expanded to Brazil to capitalize on the country’s progressive regulatory framework, which includes Brazil’s Fuel of the Future Law. The expansion also aimed to coincide with the 2025 COP30, the UN’s climate change conference, which will be hosted in Brazil in November.

Cemvita became capable of generating 500 barrels per day of sustainable oil from carbon waste at its first commercial plant in 2024, and as a result, Cemvita quadrupled output at its Houston plant. The company originally planned to reach this milestone in 2029.

Also in 2025, Cemvita announced a partnership with Brazil-based Be8 that focused on converting biodiesel byproduct glycerin into low-carbon feedstock to help support the decarbonization of the aviation sector. Cemvita agreed to a 20-year contract that specified it would supply up to 50 million gallons of SAF annually to United Airlines in 2023.

Trending News

A View From HETI

Syzygy Plasmonics will develop a facility, known as NovaSAF 1, to convert biogas into sustainable aviation fuel in Uruguay. Photo courtesy of Syzygy

Houston-based Syzygy Plasmonics announced plans to develop what it calls the world's first electrified facility to convert biogas into sustainable aviation fuel (SAF).

The facility, known as NovaSAF 1, will be located in Durazno, Uruguay. It is expected to produce over 350,000 gallons of SAF annually, which would be considered “a breakthrough in cost-effective, scalable clean fuel,” according to the company.

"This is more than just a SAF plant; it's a new model for biogas economics," Trevor Best, CEO of Syzygy Plasmonics, said in a news release. "We're unlocking a global asset class of underutilized biogas sites and turning them into high-value clean fuel hubs without pipelines, costly gas separation, or subsidy dependence.”

The project is backed by long-term feedstock and site agreements with one of Uruguay's largest dairy and agri-energy operations, Estancias del Lago, while the permitting and equipment sourcing are ongoing alongside front-end engineering work led by Kent.

Syzygy says the project will result in a 50 percent higher SAF yield than conventional thermal biogas reforming pathways and will utilize both methane and CO2 naturally found in biogas as feedstocks, eliminating the need for expensive CO2 separation technologies and infrastructure. Additionally, the modular facility will be designed for easy replication in biogas-rich regions.

The new facility is expected to begin commercial operations in Q1 2027 and produce SAF with at least an 80 percent reduction in carbon intensity compared to Jet A fuel. The company says that once fully commercialized the facility will produce SAF at Jet-A fuel cost parity.

“We believe NovaSAF represents one of the few viable pathways to producing SAF at jet parity and successfully decarbonizing air travel,” Best added in the release.

Trending News